Table 5.
List of excluded studies
| Authors | Type of study | Reason of exclusion |
|---|---|---|
| Aviles et al., 2013[68] | RCT | Oncology study |
| Badros et al., 2006[51] | Prospective observation | Oncology study |
| Badros et al., 2013[66] | Poster | Oncology study and study type |
| Bagur et al., 2010[58] | Abstract | Study type |
| Bejhed et al., 2016[78] | Case control | Unclear sample (oncology) |
| Boonyapakorn et al., 2008[53] | Prospective study | Oncology study |
| Borromeo et al., 2011[62] | Case control | Unclear sample (oncology) |
| Brahim et al., 2011[61] | Abstract | Oncology study and study type |
| Freire et al., 2020[89] | Abstract | Study type |
| Freire et al., 2020[50] | Abstract | Study type |
| Ebker et al., 2013[67] | Letter to editor | Study type |
| Estilo et al., 2008[52] | Retrospective study | Oncology study |
| Favia et al., 2015[72] | Case report | Oncology study |
| Felsenberg et al., 2009[54] | Abstract | Study type |
| Gambino et al., 2016[80] | Abstract | Oncology study and sample type |
| Hayashi et al., 2018[83] | Retrospective cohort | Unclear sample (oncology) |
| Horauf et al., 2010[57] | Abstract | Oncology study and study type |
| Jarnbring et al., 2015[75] | Retrospective case control | Oncology study |
| Kos et al., 2010[59] | Retrospective observational | Unclear sample (oncology) |
| Lazarovici et al., 2009[55] | Case control | Unclear sample (oncology) |
| Lazarovici et al., 2010[56] | Case control | Unclear sample (oncology) |
| Mizohata et al., 2014[71] | Poster | Oncology study and study type |
| Medeiros et al., 2018[84] | Abstract | Study type |
| Otto et al., 2012[17] | Retrospective observational | Oncology study |
| Paek et al., 2016[79] | Retrospective observational | Unclear methodology and results |
| Patel, 2017[82] | Letter to editor | Study type |
| Pichardo et al., 2013[70] | Case report | Unclear sample (oncology) |
| Pilanci et al., 2015[73] | Retrospective observational | Oncology study |
| Rahimi-Nedjat et al., 2016[77] | Retrospective observational | Unclear sample (oncology) |
| Shudo et al., 2018[85] | Prospective | No BRONJ cases |
| Soares et al., 2020[87] | Cross-sectional observational | Oncology study |
| Son et al., 2019[88] | Retrospective observational | Unclear sample (oncology) |
| Suzuki et al., 2017[81] | Abstract | Study type |
| Then et al., 2012[63] | Retrospective observational | Oncology study |
| Thumbiegere-Math et al., 2012[66] | Retrospective observational | Oncology study |
| Toro et al., 2011[60] | Abstract | Oncology study and study type |
| Vestergaard et al., 2012[64] | Cohort | Unclear sample (oncology) |
| Vidal Real et al., 2015[74] | Cohort | Unclear sample (oncology) |
| Watters et al., 2013[69] | Prospective observational | Unclear sample (oncology) |
| Wazzan et al., 2018[86] | Retrospective observational | Oncology study |
BRONJ=Bisphosphonate-related osteonecrosis of the jaw; RCT=Randomized controlled trials